NewAmsterdam Historical Income Statement
| NAMS Stock | 20.84 0.21 1.00% |
Historical analysis of NewAmsterdam Pharma income statement accounts such as Depreciation And Amortization of 51.5 K can show how well NewAmsterdam Pharma performed in making a profits. Evaluating NewAmsterdam Pharma income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of NewAmsterdam Pharma's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining NewAmsterdam Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether NewAmsterdam Pharma is a good buy for the upcoming year.
NewAmsterdam |
About NewAmsterdam Income Statement Analysis
NewAmsterdam Pharma Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to NewAmsterdam Pharma shareholders. The income statement also shows NewAmsterdam investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
NewAmsterdam Pharma Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of NewAmsterdam Pharma. It is also known as NewAmsterdam Pharma overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from NewAmsterdam Pharma operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of NewAmsterdam Pharma is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from NewAmsterdam Pharma's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into NewAmsterdam Pharma current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewAmsterdam Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy NewAmsterdam Stock please use our How to Invest in NewAmsterdam Pharma guide.At this time, NewAmsterdam Pharma's Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 11.8 M in 2024, despite the fact that Operating Income is likely to grow to (157.4 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 216K | 271K | 6.8M | 7.1M | Depreciation And Amortization | 4.4K | 8.4K | 49K | 51.5K |
NewAmsterdam Pharma income statement Correlations
Click cells to compare fundamentals
NewAmsterdam Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.